U.S. Food and Drug Administration grants De Novo clearance to LifeVac, classifying it as a Class II medical device for use as a second-line treatment in choking emergencies.
Class II Medical Device | 09/03/2026 | By News Bureau | 168
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy